-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

906.P1.70 906. Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders: Poster I

Symposia: Outcomes Research: Lymphoid Malignancies Excluding Plasma Cell Disorders Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Valentin Ortiz-Maldonado, MD, PhD, MSc1,2,3,4, Jacques-Emmanuel Galimard, PhD5*, Giorgio Ottaviano6*, Anna Alonso-Saladrigues, MD1,7*, Shatha Y. Farhan, MD8, Sowjanya Vuyyala, MBBS9, Eva Michel10*, Fizza Imran10*, Nazaret Sánchez-Sierra, MD11*, Nuria Martínez-Cibrián, MD12*, Samppa Ryhänen Sr., MD, PhD13,14, Richard Mitchell, MBBS15*, Stephan Mielke, MD16, Soeren Lykke Petersen, MD, MSc17*, Anne Sirvent18*, Thomas Pabst19, Jurgen Kuball, MD20, Pere Barba, MD21, Antonio Perez, MD, PhD22*, Andishe Attarbaschi, MD23,24*, Arnon Nagler, MD, MSc25,26*, Jose Antonio Pérez-Simón, MD, PhD27, Malte von Bonin, MD28*, Emma Nicholson, MD29*, David Beauvais, MD30*, Julio Delgado, MD, PhD1,3,31*, Susana Rives32*, Krzysztof Kalwak, MD, PhD33*, Fabio Ciceri, MD34*, Annalisa Ruggeri, MD, PhD35*, Adriana Balduzzi, MD6 and Sebastian Giebel, MD, PhD36*

1University of Barcelona, Barcelona, Spain
2Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
3Hospital Clínic de Barcelona, Barcelona, Spain
4Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Seattle, WA
5European Society for Blood and Marrow Transplantation, Paris, France
6Department of Pediatrics, Bone Marrow Transplant Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
7Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain
8Department of Stem Cell Transplant and Cellular Therapy, Henry Ford Hospital, Detroit, MI
9Hematology and Oncology, Mayo Clinic, Rochester, MN
10EBMT Paris Study Unit, Saint Antoine Hospital, INSERM UMR-S 938, Sorbonne University, Paris, France
11Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu de Barcelona, Barcelona, Spain
12Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Barcelona, Spain
13Children’s Hospital, University of Helsinki, Helsinki, Finland
14Pediatric Research Center, Helsinki University Hospital, Helsinki, Finland
15Kids Cancer Centre, Sydney Children`s Hospital, Sydney, Australia
16Department of Cellular Therapy and Allogeneic Stem Cell Transplantation (CAST), Karolinska Comprehensive Cancer Center and ATMP Center, Karolinska Institutet and University Hospital, Stockholm, Sweden
17Department of Hematology, Copenhagen University Hospital, Copenhagen, Denmark
18Pediatric BMT Unit, Montpellier, France
19Department of Medical Oncology, Inselspital, University Hospital Bern, University of Bern, Bern, Switzerland
20Department of Hematology, University Medical Centre, Utrecht, Netherlands
21Department of Hematology, Hospital Universitari Vall d'Hebron, Barcelona, Spain
22Pediatric Hemato-Oncology Department, Hospital Universitario La Paz, Madrid, Spain
23Department of Pediatric Hematology and Oncology, St. Anna Kinderspital, Vienna, Austria
24St. Anna Children´s Cancer Research Institute (CCRI), Vienna, Austria
25Chaim Sheba Medical Center, Tel-Hashomer, Israel
26Tel Aviv University, Tel-Hashomer, Israel
27Department of Hematology, University Hospital Virgen del Rocío, Sevilla, Spain
28University Hospital TU Dresden, Dresden, Germany
29Royal Marsden NHS Foundation Trust, London, United Kingdom
30Hematology Department, CHU Lille, Lille, France
31Instituto de Investigaciones Biomédicas August Pi i Sunyer (IDIBAPS), Barcelona, Spain
32Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Esplugues De Llobregat, Barcelona, AL, Spain
33Department of Pediatric Hematology, Oncology and BMT, Wroclaw Medical University, Wroclaw, Poland
34Ospedale San Raffaele, Milan, Italy
35Hematology and Bone Marrow Transplant Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy
36Department of Hematology and Bone Marrow Transplantation, Maria Sklodowska-Curie Institute of Oncology, Gliwice, Poland

Victoria A. Vardell, MD1 and Srinivas K Tantravahi, MD2

1Huntsman Cancer Institute, Division of Hematology and Hematological Malignancies, University of Utah, Salt Lake City, UT
2Huntsman Cancer Institute, Division of Hematology and Hematologic Malignancies, University of Utah, Salt Lake Cty, UT

Aashima Pandhi, MD1, Elleson Harper, BS2*, Rebecca Ramdhan, MD3*, Breanne Roche, DNP, APRN, CPNP-PC, CPHON4*, Yamilet Huerta, MD5* and Sanjay Ahuja, MD6

1Case Western Reserve University/ University Hospitals Rainbow Babies & Children's Hospital, Cleveland, OH
2University Hospitals Clinical Research Center, Cleveland, OH
3Casewestern Reserve University, Cleveland
4University Hospitals, Rainbow Babies & Children's Hospital, Cleveland
5UH Rainbow Babies & Children's Hospital, Cleveland, OH
6Rainbow Babies and Children's Hospital, Cleveland, OH

Varun Iyengar, MD1, Jessica Chicola, BSc2*, Ashlee Joseph, BS1*, Michelle Okwali, MPH1*, Regina Truong1*, Neil Bapodra1*, Alexander P. Boardman, MD1*, Philip Caron, MD1, Kevin A. David, MD1*, Zachary D. Epstein-Peterson, MD1, Lorenzo Falchi, MD1, Paola Ghione, MD1, Anita Kumar, MD3, Jennifer Kimberly Lue, MD1, Efrat Luttwak, MD1, Steven Horwitz, MD1, Andrew M. Intlekofer, MD, PhD1, William T. Johnson, DO4, Alison Moskowitz, MD1, Ariela Noy, MD1, Colette Owens, MD1, Maria Lia Palomba, MD1, Raphael E. Steiner, MD1, Robert Stuver, MD1, Santosha A. Vardhana, MD, PhD1, Andrew D. Zelenetz, MD, PhD1, Gilles Salles, MD, PhD1, Paul A. Hamlin, MD1 and Pallawi Torka, MD1

1Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Cooper Medical School at Rowan University, Camden, NJ
3Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
4Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY

Ida Hude1*, Anja Tea Golubić, MD, PhD2,3*, Sandra Bašić-Kinda, MD, PhD4*, Antonela Lelas, MD4*, Ida Ivek, MD4*, Helena Markotić, MD5*, Martina Morić Perić, MD6*, Dino Dujmović, MD, PhD4*, Ivo Radman, MD4*, Barbara Dreta, MD4*, Margareta Dobrenić, MD, PhD2,3*, Snježana Dotlić, MD, PhD3,7*, Ivana Ilić, MD, PhD3,7*, Dražen Huić, MD, PhD2,3* and Igor Aurer, MD, PhD3,4*

1Department of Internal Medicine, Division of Hematology, University Hospital Center Zagreb, ZAGREB, Croatia
2Department of Nuclear Medicine and Radiation Protection, University Hospital Center Zagreb, Zagreb, Croatia
3University of Zagreb School of Medicine, Zagreb, Croatia
4Department of Internal Medicine, Division of Hematology, University Hospital Center Zagreb, Zagreb, Croatia
5Department of Internal Medicine, Division of Hematology, University Hospital Mostar, Mostar, Bosnia and Herzegovina
6Department of Internal Medicine, Division of Hematology, General Hospital Zadar, Zadar, Croatia
7Department of Pathology and Cytology, University Hospital Center Zagreb, Zagreb, Croatia

Nora Balas, PhD1*, Joshua Richman2*, Wendy Landier, PhD3*, Sadeep Shrestha, PhD4*, Katia J Bruxvoort, PhD5*, Lindsey Hageman, MPH1*, Qingrui Meng, MS3*, Elizabeth Ross5*, Alysia Bosworth, BA6*, Hok Sreng Te7*, F. Lennie Wong, PhD8, Ravi Bhatia, MD9, Stephen J. Forman, MD, FACP10, Saro Armenian, DO, MPH6, Daniel Weisdorf, MD7 and Smita Bhatia, MD, MPH1

1Institute for Cancer Outcomes and Survivorship, University of Alabama at Birmingham, Birmingham, AL
2Department of Surgery, University of Alabama at Birmingham, Birmingham, AL
3University of Alabama At Birmingham, Birmingham, AL
4School of Public Health, University of Alabama at Birmingham, Birmingham, AL
5University of Alabama at Birmingham, Birmingham, AL
6City of Hope National Medical Center, Duarte, CA
7University of Minnesota, Minneapolis, MN
8City of Hope, Duarte, CA
9Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, AL
10Department of Hematology and Hematopoietic Cell Transplantation, Gehr Family Center for Leukemia Research, City of Hope National Medical Center, Duarte, CA

Kim Z Summers, PhD1*, Orlando Agrippa, BSc MBA1*, Muna Yusuf, BSc MSc1* and Shirley D'Sa, FRCP FRCPath MD(Res)2*

1Sanius Health, London, United Kingdom
2University College London Hospitals NHS Foundation Trust, London, United Kingdom

Sara Suhl, BS1,2*, Alexander Kaminsky, BS2*, Abigail Marx, BS, MPH2*, Sophia Luyten, BS2*, Ikenna David Nebo, BA2*, Barbara Pro, MD3 and Larisa J Geskin, MD4*

1Columbia University Vagelos College of Physicians and Surgeons, New York City, NY
2Columbia University Vagelos College of Physicians and Surgeons, New York, NY
3Lymphoma Program, Division of Hematology & Oncology, Columbia University, New York, NY
4Department of Dermatology, Columbia University, New York, NY

Oboseh John Ogedegbe, MD1*, Asfand Yar Cheema, MD2*, Ahmed Bashir Sukhera, MD3*, Gloria Erazo, MD3*, Jorge Rodriguez Vazquez, MD3*, Serhan Unlu, MD4 and Tabowei Godfrey5*

1Trinity Health Ann Arbor Hospital, Ypsilanti, MI
2Tauusig Cancer Institute, Cleveland Clinic, Cleveland
3Department of Internal Medicine, Texas Tech University Health Sciences Center at the Permian Basin, Odessa, TX
4Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
5Texas Tech University Health Science, Permian Basin, Odessa, TX

Andrea Kuhnl1*, Amy A Kirkwood, MSc2*, Claire Roddie, MD3,4*, Caroline Besley, MD5*, Jane Norman6*, Ben Uttenthal, MD PhD7*, Frances Seymour8*, Andrew J. Davies, MD, PhD9*, Wendy Osborne, MD10*, William Townsend11*, Emil Arjun Kumar, BMBCh12*, Amrith Mathew13*, Carlos Gonzalez Arias14*, Ceri Jones, MD, PhD, FRCPath15*, Aikaterini Panopoulou16*, Ahmed Abdulgawad, MSc, PhD, MRCP, FRCPath17*, Edward Bataillard, BMBCh18*, Pierre McCarthy19*, Nicolas Martinez-Calle20*, Vaishali Dulobdas21*, Rajesh Alajangi22*, Ram Malladi, MD, PhD23*, Muddeha Waraich6*, Olateni Awofisayo, MBBS24*, Hwai Jing Hiew, MD, FRCPath9*, Callum Harris16*, Michael Northend, MBBS25*, Adrian Maraj, FRCPath, MBBChir, MRCP12*, Shankaranarayana Paneesha, MD26, Kasys Meira-Gervatauskas22*, Kate Cwynarski, MBBS, PhD, FRCP, FRCPath27*, Graham P. Collins28, Roderick J. Johnson, MD29, Robin Sanderson, FRCPath, PhD30, Maeve O'Reilly31*, Tobias Menne, PhD32* and Sridhar Chaganti, MD, PhD, FRCPath, MRCP33*

1King’s College Hospital NHS Foundation Trust, London, United Kingdom
2Cancer Research UK & UCL Cancer Trials Centre, UCL Cancer Institute, University College London, London, United Kingdom
3Department of Haematology, University College London Hospitals NHS Foundation Trust, London, United Kingdom
4University College London Cancer Institute, London, United Kingdom
5Department of Haematology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, United Kingdom
6Manchester Royal Infirmary, Manchester, United Kingdom
7Cambridge University Hospitals, Cambridge, United Kingdom
8Leeds Teaching Hospitals NHS Trust, Leeds Cancer Centre, Leeds, United Kingdom
9University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom
10Newcastle Hospitals NHS Trust, Newcastle Upon Tyne, United Kingdom
11University College Hospital London, London, United Kingdom
12King's College Hospital, London, United Kingdom
13University Hospitals Birmingham, Birmingham, United Kingdom
14Royal Marsden Hospital, Sutton, United Kingdom
15University Hospitals Wales, Cardiff, United Kingdom
16Oxford University Hospital, Oxford, United Kingdom
17The Christie NHS Foundation Trust, Manchester, United Kingdom
18Imperial College London Hospitals, London, United Kingdom
19Sheffield Teaching Hospitals, Sheffield, United Kingdom
20Haematology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom
21Centre for Clinical Haematology, University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
22Bristol University Hospitals, Bristol, United Kingdom
23Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
24St James's Universtity Hospital Leeds, Leeds, United Kingdom
25Haematology, University College Hospital, London, United Kingdom
26Birmingham Heartlands Hospital, Birmingham, United Kingdom
27University College London Hospitals NHS Foundation Trust, London, United Kingdom
28Oxford University Hospitals, Oxford, United Kingdom
29Leeds Teaching Hospital NHS trust, Leeds, United Kingdom
30King’s College Hospital, London, United Kingdom
31Department of Hematology, University College London Hospitals, London, United Kingdom
32Northern Centre for Cancer Care, Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
33University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom

Oluwasegun Austine Akinyemi, MD1*, Olufunmilayo Abobarin-Aofolaju, MD2*, Tayo Adeoye, MD3*, Faith Abodunrin, MD4, Oreoluwa Adubi, MD5*, Seun Ikugbayigbe, MD MPH6*, Eunice Odusanya, BS7*, Mojisola Fasokun, MD MPH8*, Miriam Michael, MD9* and Kakra Hughes, MD, PHD7*

1The Clive O Callender Outcomes Research Center, Howard University College of Medicine, Macomb, IL
2Department of Pathology, National Children's Hospital, Columbus, OH
3Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
4Department of Hematology and Oncology, University of Chicago, Chicago, IL
5Ross University School of Medicine, Miramar, FL
6Eastern Illinois University, Charleston, IL
7Department of Surgery, Howard University College of Medicine, Washington, DC
8Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL
9Department of Internal Medicine, Howard University College of Medicine, Washington DC, DC

Narendranath Epperla, MD, MS1, Natalie Grover, MD2, Pallawi Torka, MD3, Reem Karmali, MD4, Kaitlin Annunzio, DO5, Marcus P. Watkins, PhD6*, Andrea Carolina Anampa-Guzmán, MD7*, Heather Reves, MS, BS8*, Montreh Tavakkoli, MD9, Beth Christian, MD10, Colin Thomas, MD11, Stefan K. Barta, MD, MS12*, Praveen Ramakrishnan Geethakumari, MD, MS8, Geoffrey Shouse, PhD, DO13, Nancy L. Bartlett, MD14 and Adam J. Olszewski, MD15

1Division of Hematology, Department of Medicine, The Ohio State University, The James Cancer Hospital and Solove Research Institute, Columbus, OH
2University of North Carolina, Chapel Hill, NC
3Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
4Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
5The James Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH
6Division of Oncology, Washington University School of Medicine, St. Louis, MO
7Roswell Park Comprehensive Cancer Center, Buffalo, NY
8Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern, Dallas, TX
9Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
10Division of Hematology, The Ohio State University, Columbus, OH
11Department of Medicine, University of Pennsylvania, Philadelphia, PA
12Perelman Center for Advanced Medicine - University of Pennsylvania, Philadelphia, PA
13City of Hope Cancer Center, Duarte, CA
14Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO
15Brown University, Providence, RI

Mazie Tsang, MD1, Brie N Noble, MS2*, Carla Casulo, MD3, Carrie A Thompson, MD, MS4, Allison C. Rosenthal, DO5, Dai Chihara, MD, PhD6, Eric Mou, MD7*, Urshila Durani, MD, MPH4, Annalynn M Williams, PhD, MS8, Michelle A.T. Hildebrandt, PhD9, Kathleen J Yost, PhD10*, Melissa C. Larson, MS10*, Brianna Gysbers11*, Matthew J. Maurer, DSc10, Andrew L. Feldman, MD12, David L. Jaye, MD13, Jon Tilburt, MD, MPH14*, Ajay Major, MD, MBA15, Talal Hilal, MD16, Yucai Wang, MD, PhD4, Amber Koehler, PA-C17*, Timothy G. Call, MD4, Sameer A. Parikh, MBBS4, Javier L. Munoz, MD, MS, MBA18, Gita Thanarajasingam, MD4, Loretta Nastoupil6*, Grzegorz S. Nowakowski, MD19, Jonathon B. Cohen, MD, MS20, Thomas M. Habermann, MD4, Christopher Strouse, MD21, Izidore S. Lossos, MD22, Brad S. Kahl, MD23, Peter Martin, MD24, Christopher R. Flowers, MD, MS6, James R. Cerhan, MD, PhD25 and Amylou C Dueck, PhD2

1Division of Hematology and Oncology, Department of Medicine, Mayo Clinic, Phoenix, AZ
2Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ
3Division of Hematology and Medical Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY
4Division of Hematology, Mayo Clinic, Rochester, MN
5Division of Hematology/Oncology Mayo Clinic, Phoenix, AZ
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
7Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
8University of Rochester Medical Center - James P. Wilmot Cancer Center, Rochester, NY
9Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
10Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
11Department of Health Sciences Research, Mayo Clinic, Rochester, MN
12Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
13Department of Pathology and Laboratory Medicine, Emory University, Atlanta, GA
14Mayo Clinic, Scottsdale, AZ
15The University of Chicago Comprehensive Cancer Center, Denver, CO
16Division of Hematology, Mayo Clinic, Phoenix, AZ
17Division of Hematology, Department of Medicine, Mayo Clinic, Rochester
18Mayo Clinic Arizona, Phoenix, AZ
19Mayo Clinic, Rochester, MN
20Winship Cancer Institute, Emory University, Atlanta, GA
21Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Hospitals and Clinics, Iowa City, IA
22Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
23Siteman Cancer Center, Division of Oncology, Washington University School of Medicine in St. Louis, St. Louis, MO
24Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
25Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN

Christopher G. Pelligra1*, Fjoralba Kristo2*, Yutian Mu3*, Justin Ferdinandus, MD4*, Karolin Behringer4*, Janina Jablonski4*, Peter Borchmann, MD4 and Ajibade Ashaye, MD, MS, MBA, MPH2

1Evidera, Atlanta, GA
2Takeda Development Center Americas, Inc., Cambridge, MA
3Evidera, Waltham, MA
4German Hodgkin Study Group and Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Düsseldorf, University of Cologne, Cologne, Germany

Tarun Jain, MD, MSc1,2,3, Xu Ji, PhD2,3, Nicholas Degroote, MPH4*, Alexandra Himes, DO5*, Cortland Coxhead, MD6*, Rebecca Williamson Lewis, MPH3*, Anjali Khanna, MBBS, MPH2*, Alexandra Cathcart, MD, MSc7*, Tamara P. Miller, MD, MSCE2,3, Kristie A. Blum, MD8,9, Keiko Tarquinio, MD5,10* and Sharon M. Castellino, MD, MSc2,3

1Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA
2Department of Pediatrics, Division of Hematology, Oncology, and Bone Marrow Transplant, Emory University School of Medicine, Atlanta, GA
3Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
4Centers for Disease Control and Prevention, Atlanta, GA
5Department of Pediatrics, Division of Critical Care Medicine, Emory University School of Medicine, Atlanta, GA
6Department of Pediatrics, Emory University School of Medicine, Atlanta, GA
7The Children's Hospital of Philadelphia, Philadelphia, PA
8Emory University / Winship Cancer Institute, Atlanta, GA
9Winship Cancer Institute of Emory University, Atlanta, GA
10Department of Healthcare Leadership and Management, Master of Science in Health Informatics Program, Medical University of South Carolina, Charleston, SC

Verena Pfister1,2*, Fernanda de Morais Marques, MD2,3,4*, Vinicius Campos de Molla, MD, PhD5,6*, Flavia Parra7*, Mihoko Yamamoto, MD2,8*, Rodrigo Santucci9*, Milton A. F. Aranha, MD10*, Valeria Buccheri, MD, PhD11*, Glaciano Ribeiro, MD12*, Vera Figueiredo, MD13*, Nelson Hamerschlak, MD, PhD14, Abel Costa Neto, MD15, Jayr Schmidt Filho, MD16*, Talita Silveira, MD, PhD17*, Adriana Scheliga, MD, MSc18*, Matheus Vescovi Goncalves, MD, PhD8*, Leila Perobelli, MD19*, Carlos Chiattone, MD, PhD20,21 and Celso Arrais-Rodrigues, MD, PhD2,22,23

1Division of Hematology - UNIFESP, Sao Paulo, AC, Brazil
2Brazilian Registry of CLL – Associação Brasileira de Hematologia e Hemoterapia, Sao Paulo, Brazil
3Hospital de Transplantes Euryclides de Jesus Zerbini – Hospital Brigadeiro. São Paulo – Brazil, Sao Paulo, Brazil
4Division of Hematology - UNIFESP. São Paulo – Brazil, São Paulo, Brazil
5Hospital Nove de Julho, DASA, São Paulo, Brazil
6Universidade Federal de São Paulo, São Paulo, Brazil
7Brazilian Registry of CLL – Associação Brasileira de Hematologia e Hemoterapia, Sao Paulo, BRA
8Division of Hematology - UNIFESP. São Paulo – Brazil, Sao Paulo, Brazil
9HEMOMED, Sao Paulo, AM, BRA
10HEMOMED- BRAZIL, São Paulo, BRA
11Instituto do Câncer do Estado de São Paulo/Hospital das Clinicas - Faculdade de Medicina da Universidade de São Paulo, São Paulo -, São Paulo, Brazil
12Universidade Federal de Minas Gerais. Belo Horizonte, Minas Gerais - Brazil, Belo Horizonte, Brazil
13Hospital do Servidor Público do Estado de São Paulo – IAMSPE. São Paulo – Brazil, Sao Paulo, Brazil
14Hematology, Albert Einstein Hospital, São Paulo, Brazil
15Department of Hematology, D'Or Institute for Research and Education, São Paulo, Brazil
16AC Camargo Cancer Center, Sao Paulo, BRA
17AC Camargo Cancer Center, São Paulo, Brazil
18Grupo Oncoclinicas, Rio de Janeiro, BRA
19Hospital de Transplantes Euryclides de Jesus Zerbini / Hospital Brigadeiro, São Paulo, Brazil
20Hospital Samaritano-Higienopolis, Sao Paulo, Brazil
21Santa Casa Medical School of Sao Paulo, Sao Paulo, Brazil
22Division of Hematology - UNIFESP, São Paulo, Brazil
23Hospital Nove de Julho - DASA, São Paulo, Brazil

John N. Allan, MD1, Christopher P Fox, MD, PhD2, Grzegorz S. Nowakowski, MD3, Peter A Riedell, MD4*, Tycel J. Phillips, MD5, Anthony W Wang, PhD, MPH6*, Abualbishr Alshreef, PhD6*, Junhua Yu, PhD7*, Cheng Chen, PhD8*, Kavita Sail, PhD7*, Diala Harb, PharmD, PhD6*, Alex Mutebi, PhD9*, Anindit Chhibber, PhD9*, Brian Elliot, MD10*, Mohammad Atiya, PharmD9* and Catherine Thieblemont11*

1Division of Hematology and Oncology, Weill Cornell Medicine, Long Island City, NY
2School of Medicine, University of Nottingham, Nottingham, United Kingdom
3Mayo Clinic, Rochester, MN
4David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
5City of Hope, Duarte, CA
6AbbVie, Inc., North Chicago, IL
7AbbVie Inc., North Chicago, IL
8AbbVie, Inc, North Chicago, IL
9Genmab US Inc, Plainsboro, NJ
10Genmab US, Inc., Plainsboro, NJ
11Assistance Publique & Hôpitaux de Paris (APHP), Hôpital Saint-Louis, Hémato-oncologie, Université de Paris, Paris, FRA

Sara Leidy, PharmD1*, Jordan Snyder, PharmD2,3*, James A Davis, PharmD4*, William Wesson, MD, MPH1, Brian Hess, MD5, Ryan Jacobs6, Madalyn Edmonds1*, Nausheen Ahmed, MD3,7 and Marc Hoffmann, MD8

1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Cancer Center, Westwood, KS
2Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Overland Park, KS
3US Myeloma Innovations Research Collaborative (USMIRC), Kansas City, KS
4Medical University of South Carolina Hollings Cancer Center, Charleston, SC
5Hollings Cancer Center, Medical University of South Carolina, Charleston, SC
6Department of Hematologic Oncology and Blood Disorders, Atrium Health Levine Cancer Institute, Charlotte, NC
7Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Westwood, KS
8Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS

Neela Easwar, MD1*, Anna Alperovich, MD2, Alexandra Gomez-Arteaga, MD2, Sebastian A. Mayer, MD2, Nora Chokr, MD3, Adrienne A. Phillips, MD, MPH2, Jingmei Hsu, MD, PhD4, Koen van Besien, MD, PhD5, Matthew Gromowsky6, Matthew Lunning, DO6, Tsiporah B. Shore, MD2, Juliet N Barker, MBBS1 and Samuel Yamshon, MD2*

1Department of Medicine, NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY
2Department of Hematology & Medical Oncology, NewYork-Presbyterian/Weill Cornell Medical Center, New York, NY
3Department of Hematology & Medical Oncology, NewYork-Presbyterian/Weill Cornell Medical Center, Brooklyn, NY
4Blood and Marrow Transplantation and Cellular Therapy, NYU Langone Health, New York, NY
5Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH
6University of Nebraska Medical Center, Omaha, NE

Juan Rangel-Patiño, MD1, John Kuruvilla, MD, FRCPC2, Anca Prica, MD3, Robert Kridel, MD, PhD2, Sita D. Bhella, MD4, Vishal Kukreti, MD, MSc5, Jan Delabie, MD, PhD6*, Abi Vijenthira, MD, SM5, Manjula Maganti7* and Michael Crump, MD2*

1Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
2Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
3Divison of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, ON, Canada
4Princess Margaret Cancer Centre, Toronto, ON, Canada
5Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
6Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, ON, Canada
7Department of Biostatistics, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada

Jing-Zhou Hou, MD, PhD1, Rushir Choksi, MD1*, Gregory A. Maglinte2*, Anupama Vasudevan, BDS, MPH, PhD3*, Anna Rui, MPH3*, Brandon Wang, MBA3*, Hoa Pham, PharmD2*, Ann Lasn2* and Simon Blanc, MD3

1University of Pittsburgh Medical Center, Pittsburgh, PA
2BeiGene USA, Inc, Los Angeles, CA
3IntegraConnect PrecisionQ, West Palm Beach, FL

Jessica M Allen, MD1*, Keegan Carroll1*, Dennis Gurfinkel, MPH2*, Caroline Tietbohl, PhD, MA2*, Brooke Dorsey Holliman, PhD, MA2*, Joseph Krongold, MA3*, Jamie L Studts, PhD4*, Fay Hlubocky, PhD, MA3*, Christopher K Daugherty, MD3* and Ajay Major, MD, MBA1

1Division of Hematology, University of Colorado School of Medicine, Aurora, CO
2Adult & Child Center for Outcomes Research & Delivery Science, University of Colorado School of Medicine, Aurora, CO
3Section of Hematology/Oncology, The University of Chicago, Chicago, IL
4Division of Medical Oncology, University of Colorado School of Medicine, Aurora, CO

Wen Gao1*, Yaxiao Lu1*, Xianhuo Wang, MD2* and Huilai Zhang, MD3

1Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
2Department of Lymphoma, Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
3Department of Lymphoma, Tianjin Medical University Cancer Hospital, Tianjin, China

Antonio Gutiérrez1*, Izaskun Zeberio2*, Pilar Martinez-Barranco3*, Francisco Javier Peñalver4*, Sandra Pérez5*, Daniel Morillo, MD6*, Xabier Mart N Martitegui7*, Concepción Nicolás8*, Ainara Ferrero9*, Ana Jiménez Ubieto10*, Mariana Bastos-Oreiro11,12*, Julio Dávila-Valls13*, Maria Victoria Calle Gordo, BMBS,14*, María Pérez Sala, MD15*, Guillermo Rodríguez Garcia16*, Aranzazu Alonso Alonso, MD17*, Ana Garcia Noblejas, MD, PhD18*, Diana Sanchez Arguello19*, Teresa Knight Asorey, MD20*, Maria Angeles Fernandez Fernandez21*, Javier López Marin, MD22*, Jaime Perez de Oteyza23,24*, Sonia González De Villambrosia25*, Elena Perez Ceballos26*, Alejandro Marin27*, Belén Navarro28*, Ruben Fernandez Alvarez, MD29*, Pilar Gómez30*, Jose Antonio Hueso31*, Maria Jesus Penarrubia Ponce32*, Pilar Bravo33*, Daniel García Belmonte34*, Haridian De La Nuez Melian35*, Sara Nistal36*, Pau Abrisqueta Costa37*, Fernanda Ibañez38*, Luis Palomera, MD, PhD39*, Eva Donato40*, Andrea Provencio Rincon41*, Maria Stefania Infante, MD42* and Eva Gonzalez Barca43*

1Unit of Lymphoma. Department of Hematology. Son Espases University Hospital (IdISBa), Palma de Mallorca, Spain
2Hematology Department, Hospital Universitario Donostia, San Sebastian, ESP
3Hospital de Alcorcon, Alcorcon, ESP
4Hospital de Alcorcon, Alcorcon, Spain
5Hematology Department., Hospital Universitario Son Espases, IdISBa., Palma, Spain
6Hematology Department, Hospital Universitario Fundación Jiménez Díaz, LAS ROZAS, Spain
7Hospital de Cruces, Baracaldo( Vizcaya), ESP
8Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain
9University Hospital Arnau de Vilanova, Lleida, Spain
10Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
11Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
12Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
13Hospital Universitario Nuestra Senora de Sonsoles, Avila, ESP
14Hospital Torre Cardenas, Torrecardenas, Spain
15Hospital de Elda, ELDA, Spain
16Hospital Universitario Virgen del Rocío, Seville, Spain
17Hospital Universitario Quirónsalud Madrid, Madrid, Spain
18Hematology Department, Hospital Universitario La Princesa, Madrid, Spain
19Hospital de Laredo, Laredo, Spain
20Servicio de Hematología. Hospital Universitario Lucus Augusti, Lugo, Spain
21Hospital de Pontevedra, Vigo, Pontevedra, ESP
22Hospital Universitario Dr.Balmis, Alicante, Spain
23Universidad CEU San Pablo, Madrid, Spain
24Clinical Hematology and Oncohematology, Hospital Universitario HM Sanchinarro, Madrid, Spain
25Hematology Department, Hospital Universitario Marqués de Valdecilla (IDIVAL), Santander, Spain
26Hospital Universitario Morales Meseguer, MURCIA, ESP
27Hospital Nuestra Señora de Candelaria, Tenerife, Spain
28Hematology Department, Hospital Universitario Puerta de Hierro, Majadahonda, Spain
29Hospital de Cabueñes, Gijón, Spain
30Hospital La Paz, Madrid, Spain
31Hospital de la Plana de Castellon, Castellon, Spain
32H. Clínico de Valladolid, Valladolid, ESP
33H. de Fuenlabrada, Fuenlabrada, Spain
34Hematology Department, Hospital Universitario la Zarzuela, Madrid, Spain
35Hospiral Dr. Negrin, Madrid, ESP
36H. de la Moncloa, Madrid, Spain
37University Hospital Vall d’Hebron, Barcelona, Spain
38H. de la Vega Baja, Orihuela, Spain
39Hospital Clinico Universitario Lozano Blesa, Instituto Investigacion Sanitaria Aragon, Zaragoza, Spain
40Hematology Department, Hospital Universitario Doctor Peset, Valencia, Spain
41Hospital de Manacor, Manacor, ESP
42HOSPITAL INFANTA LEONOR, Madrid, Madrid, ESP
43Department of Hematology, Department of Clinical Sciences, Institut Català d'Oncologia, Hospitalet de Llobregat, Barcelona University, Barcelona, Spain

Meagan Harrington, BA1*, Amon Chirwa2*, Edwards Kasonkanji, MPH2*, Lusayo Simwinga2*, Noel Mumba2*, Maria Chikasema2*, Phaleda Kumwenda2*, Matthew S Painschab, MD2,3 and Yuri D. Fedoriw, MD2,4

1UNC Project-Malawi, Lilongwe, TT, Malawi
2UNC Project-Malawi, Lilongwe, Malawi
3Division of Hematology, University of North Carolina, Chapel Hill, NC
4Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC

Thomas Chatzikonstantinou, MD1*, Maria Vasilopoulou1*, Dimitrios Kyrou1*, Georgios Karakatsoulis1*, Panagiotis Argyropaidas2*, Sotiria Besikli-Dimou1*, Panos Bonotis1*, Maria Chatzimina2*, Jana Didi3*, Christos Demosthenous, MD4*, Tina Garani-Papadatos5*, Stefan Hoffman6*, Christine Kakalou1*, Eleni Kazantzaki7*, Stephan Kiefer8*, Lefteris Koumakis2*, Eva Hellstrom Lindberg, MD, PhD9*, Julie Ling10*, Christos Maramis1*, Marcel Meyerheim11*, Cathy Payne10*, Heather Parker12*, Sheila Payne13*, Charalampos Pontikoglou7*, Riley Reston12*, Harriet Ryblom14*, Annette Sander15*, Fatima Schera16*, Karin Ekstroem Smedby, MD17, George Zacharioudakis2*, Anastasia Chatzidimitriou1*, Michael Doubek, Prof18, Niki Stavrogianni, MD19*, Paolo Ghia, MD, PhD20,21, Eleni Papadaki22*, Richard Rosenquist, MD, PhD23,24, Norbert Graf11*, Pantelis Natsiavas, PhD1*, Kostas Stamatopoulos1*, Christina Karamanidou1* and Lydia Scarfo, MD20,25

1Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki, Greece
2Institute of Computer Science, Foundation for Research and Technology-Hellas, Heraklion, Greece
3Center for Molecular Medicine, Central European Institute of Technology, Masaryk University, Brno, Czech Republic
4Hematology Department – BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece
5Department of Public Health Policy, School of Public Health, University of West Attica, Athens, Greece
6Promotion Software GmbH, Berlin, Germany
7Department of Hematology, University of Crete School of Medicine, Heraklion, Greece
8Fraunhofer Institute For Biomedical Engineering (IBMT), Sulzbach, Germany
9Center for Hematology and Regenerative Medicine (HERM), Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden
10European Association for Palliative Care, Vilvoorde, Belgium
11Department of Pediatric Oncology and Hematology, Faculty of Medicine, Saarland University, Homburg, Germany
12Atlantis Health, London, United Kingdom
13International Observatory on End-of-Life Care, Faculty of Health and Medicine, Lancaster University, Lancaster, Greece
14Hematology Center, Karolinska University Hospital and Institutet, Stockholm, Sweden
15Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Greece
16Institute for Biomedical Engineering, Sulzbach, Germany
17Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
18Department of Internal Medicine – Hematology and Oncology, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic
19Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
20Strategic Research Program on CLL, IRCCS Ospedale San Raffaele, Milano, Italy
21Università Vita-Salute San Raffaele, Milano, Italy
227. Department of Hematology, University of Crete School of Medicine, Heraklion, Greece
23Department of Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden
24Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
25Università Vita-Salute San Raffaele, Milan, Italy

Yao Yao, MBBS1*, Serif Sungur, BMedSci (Hons)2*, Cameron Wellard, BSc (Hons), PhD3*, Eliza Chung, BSc, MPH4*, Susan Morgan, MBBS, FRACP, FRCPA5*, Denise Lee, MBBS6,7*, Geoffrey Chong, MD8*, Chan Y. Cheah, MBBS DMSc9,10, Eliza A. Hawkes, MD11,12, Erica M. Wood, MBBS, PhD, FRACP, FRCPA13*, Nada Hamad, MBBS, MSc, BSc14, Anna M. Johnston, FRACP, MBBS, FRCPA15 and Tasman Armytage, MBBS, BSc, FRACP, FRCPA16*

1Department of Haematology, Gosford Hospital, Gosford, NSW, Australia
2School of Medicine, University of Tasmania, Launceston, TAS, Australia
3School of Public Health and Preventative Medicine, Monash University, Melbourne, VIC, Australia
4Monash University, Melbourne, AUS
5Alfred Health, Melbourne, VIC, Australia
6Eastern Health, Box Hill, Australia
7Austin Hospital, Melbourne, VIC, Australia
8Ballarat Regional Integrated Cancer Centre, Ballarat, VIC, Australia
9Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
10Medical School, University of Western Australia, Perth, Western Australia, Australia
11School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
12Austin Health, Olivia Newton-John Cancer Research & Wellness Centre, Melbourne, Australia
13School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia
14St Vincent's Hospital, Sydney, NSW, Australia
15Royal Hobart Hospital, Hobart, Australia
16Gosford Hospital, Gosford, Australia

Naseem S. Esteghamat, MD1, Ann Brunson, MS2*, Renata Abrahao, MD, MSc, PhD2*, Aaron S. Rosenberg, MD3, Sara J. Schonfeld, PhD4*, Christa L Meyer, MS5*, Jeffery J. Auletta, MD5, Julianne JP Cooley6*, Lori Muffly, MD7, Lindsay M. Morton, PhD4*, Ted Wun, MD2,8 and Theresa H.M. Keegan, PhD, MS2,9

1UC Davis Comprehensive Cancer Center, Sacramento
2Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA
3UC Davis Comprehensive Cancer Center, Sacramento, CA
4Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD
5CIBMTR® (Center for International Blood and Marrow Transplant Research), NMDP, Minneapolis, MN
6California Cancer Reporting and Epidemiologic Surveillance Program, University of California, Davis, Sacramento, CA
7Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
8Division of Hematology/Oncology, University of California Davis Department of Medicine, Sacramento, CA
9University of California, Davis, Sacramento, CA

Heidi Cho, MD1, Kausik Maiti, MD2*, Chris Learn, PhD3*, Nancy Lunney, MA3* and Vladimir Otasevic, MD, PhD3*

1Parexel, Denver, CO
2Parexel, , Durham, NC
3Parexel, Durham, NC

Mazyar Shadman, MD, MPH1,2, Jennifer S. Harper, PhD3*, Alex Bokun, PharmD4*, Gloria HJ Graf, PhD5* and Xiaoxiao Lu6*

1Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
2Division of Hematology and Oncology, University of Washington, Seattle, WA
3Janssen Scientific Affairs, LLC, Titusville, NJ
4Janssen US Medical Affairs, Horsham, PA
5Janssen Scientific Affairs, Raritan, NJ
6Janssen Scientific Affairs, LLC, Horsham, PA

Steven Barker, DO1*, Asad Bashey, MD, PhD2, Lizamarie Bachier-Rodriguez2*, Lawrence E Morris, MD2, H Kent Holland1*, Justin Laporte3*, Scott R. Solomon, MD2, Melissa Sanacore, PharmD2* and Melhem Solh, MD4*

1Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, atlanta, GA
2Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Atlanta, GA
3The Blood and Marrow Transplant Program, Northside Hospital Cancer Institute, Buford, GA
4Blood and Marrow Transplant Program, BMT of GA, atlanta, GA

Ana Cristina Tejada Vasquez, MD, Gerardo Garcia-Salas, MD, Luis Paulo Ugarte Pelaez, MD*, Yadith Karina Lopez-Garcia, MD, Antonio Vega Mateos, MD, Perla R. Colunga-Pedraza, MD, Luz Tarin-Arzaga, MD*, Andres Gomez-De Leon, MD, Olga Cantu, MD*, Jose Carlos Jaime-Pérez, MD* and David Gomez-Almaguer, MD

Servicio de Hematología, Hospital Universitario "Dr. Jose Eleuterio Gonzalez", Universidad Autónoma de Nuevo León, Monterrey, Mexico

Supriya Peshin, MBBS1, Shivani Modi2* and Nagaishwarya Moka, MD3

1Ballad Health, Norton, TN
2Jefferson Einstein Healthcare Network, Norristown, PA
3Lincoln memorial university, harrogate, TN

Erin Frost, MD1, Adrianna Westbrook2*, Tracy Huang3*, Muna Qayed, MD4, Benjamin Watkins, MD5, Kirsten M. Williams, MD6, Alan Bidgoli, DO2 and Michelle L Schoettler, MD7*

1Children's Healthcare of Atlanta, Emory University Hospital, Atlanta, GA
2Emory University Hospital, Atlanta, GA
3Emory University, Atlanta, GA
4Emory University, Winship Cancer Institute, Atlanta, GA
5Tulane University, New Orleans
6Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
7Children's Healthcare of Atlanta, Atlanta, GA

Joseph P. McGuirk, DO1, Mark Fesen, MD2, Scott D. Ramsey, MD PhD3*, Rony Abou-Jawde, MD4, Anthony Proli, PharmD5*, Hil Hsu, PhD, MPH, BS6*, Anik R Patel, PhD6, Miguel-Angel Perales, MD7, Blythe Adamson8*, Jiarui Fu9* and Jeremy Snider10*

1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Ctr., Westwood, KS
2Central Care Cancer Center, Great Bend, KS
3Fred Hutchinson Cancer Center, Seattle, WA
4Mosaic Life Care, St. Joseph, MO
5Flatiron Health, Inc, Philadelphia, PA
6Kite, a Gilead Company, Santa Monica, CA
7Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
8Flatiron Health, New york, NY
9Flatiron health, new york, NY
10Flatiron Health, New York, NY

Olivia Leighton Makos1*, Valerie K Shostrom, MS1*, James Olen Armitage, MD1, Julie M. Vose, MD, MBA2, Matthew Lunning, DO1, Robert Gregory Bociek, MD, MSc1 and Christopher R D'Angelo, MD3

1University of Nebraska Medical Center, Omaha, NE
2Department of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE
3University of Nebraska Medical Center, Bennington, NE

Marina Gomez-Llobell, MD1*, Roni Shouval, MD, PhD1,2, Samantha Brown3*, Noa Golan Accav4,5*, Sean M. Devlin, PhD3*, Magdalena Corona, MD, PhD1*, Kai Rejeski, MD1, Alfredo Rivas-Delgado, MD, PhD6, Alejandro Luna, MD, PhD1*, Efrat Luttwak, MD6, Sandeep S. Raj, MD1, Mohammad Alhomoud, MD1, Ronit Marcus, MD7,8*, Avichai Shimoni, MD9,10*, Shimrit Ringelstein-Harlev11*, Alexander P. Boardman, MD2,6*, Parastoo B Dahi, MD2,12*, Richard J. Lin, MD, PhD2,13, Michael Scordo, MD2,12, Lorenzo Falchi, MD14, Gunjan L. Shah, MD2,15, Maria Lia Palomba, MD2,6, Gilles Salles, MD, PhD2,6, Jae H. Park, MD2, Ofrat Beyar-Katz, MD, PhD16,17*, Abraham Avigdor, MD18,19,20 and Miguel Angel Perales, MD1,2,14,15,21,22,23

1Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
2Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel aviv, Israel
5School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel-Aviv, Israel
6Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Division of Hematology and Bone Marrow Transplantation, The Chaim Sheba Medical Center, Ramat Gan, Israel
8School of Medicine, Faculty of Medical and health Sciences,Aviv University, Tel Aviv, Israel
9Division of Hematology and Bone Marrow Transplantation Department, Chaim Sheba Medical Center, Tel-Aviv, Israel
10School of Medicine, Faculty of Medical and health Sciences,Aviv University, Tel-Aviv, Israel
11Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus;The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel
12Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
13Adult BMT Service; Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
14Memorial Sloan Kettering Cancer Center, New York, NY
15Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
16Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus; The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel
17Rambam Health Care Campus;The Ruth and Bruce Rappaport Faculty of Medicine, Haifa, Israel
18Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Tel-Aviv, Israel
19School of Medicine, Faculty of Medical and health Sciences, Aviv University, Tel Aviv, Israel
20Division of Hematology and Bone Marrow Transplantation, Chaim Sheba Medical Center, Ramat Gan, Israel
21Cellular Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
22Department of Medicine, Adult Bone Marrow Transplant Service, Cellular Therapy Service, Memorial Sloan Kettering Cancer Center,, New York
23Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY

Ana Milena Cantillo Garcia Jr., MD1*, German R. Stemmelin Sr., MD2*, Sofía Gabriela Rivarola, MD2*, Maria Elvira Enciso Arrua, MD3*, Seisha Von Glasenapp, PhD4*, Fernando Warley, MSc, MD5*, Maria Orlova, MD6*, Rosa Oliday Rios Jiménez7*, Jule F Vasquez, MD8, Alfredo Quiroz, MD3*, Marialejandra Torres Viera, MD9*, Denisse Castro, MD10, Victoria Irigoin, MD11*, Brady E Beltran, MD12,13*, Henry Quintero, MD14,15*, Julio Dámaso Fernández-Águila, MD16*, Ana Carolina Oliver, MD17, Jorge J. Castillo, MD18, Luis Mario Villela, MD19*, Diego Fernando Garcez Paz20*, Bryan Valcarcel, MD, MPH21 and Luis Malpica, MD22*

1Hospital Britanico, Buenos Aires, BA, Argentina
2Hospital Británico, Buenos Aires, Argentina
3Departamento de Hematología, Hospital Central Instituto de Previsión Social, Asunción, Paraguay
4Departamento de Hematología, Hospital Central Instituto de Previsión Social, Asuncion, Paraguay
5Italian Hospital, Buenos Aires, Argentina
6Hospital Italiano de Buenos Aires, Buenos Aires, Argentina
7Hospital Clínico Quirúrgico Hermanos Amejeiras, La Habana, Cuba
8Instituto Nacional de Enfermedades Neoplasicas, Lima, Peru
9Unidad Linfomas, Instituto Hematología y Oncología Universidad Central Venezuela, Caracas, Venezuela (Bolivarian Republic of)
10Hospital Edgardo Rebagliati Martins, Lima, Peru
11Hospital de Clinicas, Montevideo, Uruguay
12Instituto de Investigación en Ciencias Biomédicas, Universidad Ricardo Palma, Lima, Peru
13Servicio Oncología Médica, Hospital Edgardo Rebagliati, Lima, Peru
14Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, Colombia
15Clinica la Estancia, Popayan, Colombia
16Gustavo Aldereguía University Hospital, Cienfuegos, CUB
17Hospital Britanico de Uruguay, Montevideo, Uruguay
18Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
19Mexico, Mexico City, Mexico
20Instituto Nacional de Oncologia Ospedale INOOS, Ibague, Colombia
21Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Houston, TX
22Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Oluwasegun Austine Akinyemi, MD1*, Olufunmilayo Abobarin-Aofolaju, MD2*, Faith Abodunrin, MD3, Tayo Adeoye, MD4*, Oreoluwa Adubi, MD5*, Mojisola Fasokun, MD MPH6*, Seun Ikugbayigbe, MD MPH7*, Eunice Odusanya, BS8*, Miriam Michael, MD9* and Kakra Hughes, MD, PHD8*

1The Clive O Callender Outcomes Research Center, Howard University College of Medicine, Macomb, IL
2Department of Pathology, National Children's Hospital, Columbus, OH
3Department of Hematology and Oncology, University of Chicago, Chicago, IL
4Department of Hematology and Oncology, Mayo Clinic, Jacksonville, FL
5Ross University School of Medicine, Miramar, FL
6Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL
7Eastern Illinois University, Charleston, IL
8Department of Surgery, Howard University College of Medicine, Washington, DC
9Department of Internal Medicine, Howard University College of Medicine, Washington DC, DC

Andre De Menezes Silva Corraes, MD1*, Anmol Baranwal, MBBS1*, Radhika Bansal, MBBS2*, Mark Gurney, MB, BCh, BAO1*, Allison C. Rosenthal, DO3, Mohamed A. Kharfan-Dabaja, MD, MBA4, Arushi Khurana, MBBS1, Patrick B. Johnston, MD, PhD5*, Stephen M. Ansell, MD, PhD1, Prashant Kapoor, MD5, Morie A. Gertz, MD1, Shaji Kumar, MD1, David Dingli, MD, PhD1, Urshila Durani, MD, MPH1, Jose C. Villasboas Bisneto, MD5, Saad S. Kenderian, MD1, Hassan B Alkhateeb, MD1*, Yi Lin, MD, PhD1, Yucai Wang, MD, PhD1 and Mithun V Shah, M.D., Ph.D.1

1Division of Hematology, Mayo Clinic, Rochester, MN
2Division of Hematology, Mayo Clinic, Bismarck, ND
3Division of Hematology/Oncology Mayo Clinic, Phoenix, AZ
4Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
5Mayo Clinic, Rochester, MN

Lihua E. Budde1, Adam J. Olszewski, MD2, Bei Hu, MD3, Nikesh Shah4*, Connie Lee Batlevi5, Shen Yin5*, Iris To5*, Michael C. Wei5, Martine Kallemeijn6*, Victor Orellana-Noia5*, Lisa Musick5*, Natasha Shamas5*, Navdeep Pal5*, Ashwini Shewade5* and Jason R. Westin, MD7

1City of Hope National Medical Center, Duarte, CA
2Brown University, Providence, RI
3Atrium Health Levine Cancer Institute, Wake Forest School of Medicine, Charlotte, NC
4Tampa General Hospital Cancer Institute, Tampa, FL
5Genentech, Inc., South San Francisco, CA
6F. Hoffmann-La Roche Ltd, Basel, Switzerland
7The University of Texas MD Anderson Cancer Center, Houston, TX

Adam Kidwell, MD1*, Fateeha Furqan, MBBS2, Emilie Aschenbrenner, PharmD3*, Walter Longo, MD4*, Sumana Devata, MD5, Mehdi Hamadani, MD6, Timothy S. Fenske, MD7 and Nirav N. Shah, MD8

1Froedtert Hospital Cancer Center, Medical College of Wisconsin, Milwaukee, WI
2Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
3Medical College of Wisconsin, Milwakee, WI
4Medical College of Wisconsin, Division of Hematology/Oncology, Milwaukee, WI
5Medical College of Wisconsin, Milwaukee, WI
6Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
7Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI
8Medical College of Wisconsin, Brookfield, WI

Kimberly Saverno, PhD1*, Loretta Nastoupil2*, Bruce Feinberg, DO3, John Galvin, MD, MPH4, Prathamesh Pathak3*, Theresa Amoloja1*, Danielle Gentile, PhD3*, Parisa Asgarisabet3* and Narendranath Epperla, MD MS5

1Incyte Corporation, Wilmington, DE
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3Cardinal Health, Dublin, OH
4Senior Medical Director, Incyte Corporation, Wilmington, DE
5The Ohio State University, Columbus, OH

Ramon Garcia-Sanz, MD, PhD1, Anna Sureda Balari, MD, PhD2, Eva Domingo Domenech, MD3*, Francisco Javier Capote Huelva4*, Antonio Gutierrez, MD, PhD5*, Antonia Rodriguez Izquierdo6*, Marta Grande De Domingo7,8* and Lourdes Baeza, PhD9*

1General University Hospital Gregorio Marañón, Madrid, Spain
2Institut Catala D'oncologia, Hospital Duran i Reynals. IDIBELL. L'Hospitalet de Llobregat, Barcelona, Spain
3Institut Catala D'oncologia, Hospital Duran i Reynals. IDIBELL. L'Hospitalet de Llobregat, Barcelona, ESP
4Hospital Universitario Puerta del Mar, Cadiz, ESP
5Hematology Department, Hospital Universitario Son Espases, IdISBa, Palma de Mallorca, Spain
6Hospital Universitario 12 de Octubre, Madrid, Spain
7Universidad de Alcalá, Alcalá de Henares, Madrid, Spain
8Medical Department, Takeda Farmacéutica España S.A, MADRID, ESP
9Medical Department, Takeda Farmacéutica España S.A, Madrid, Madrid, Spain

John Sharp, MD1, Paolo Strati, MD2, Subodh Bhatta, PhD3, Jennifer J. Huang, MD, PhD4, Colin Thomas, MD5, Daniel K Reef, MD6, Alexander Gorzewski7*, Catherine Reinert8*, Andinet Teferra9*, Ari Pelcovits, MD10, Thomas Ollila, MD11, Joseph E. Maakaron, MD12, Manali K. Kamdar, MD13, Lindsey Fitzgerald, MD14, Reem Karmali, MD15, Natalie Grover, MD16, Stefan K. Barta, MD17, Timothy Voorhees, MD, MSc18, Mazyar Shadman, MD, MPH19, Sairah Ahmed, MD2 and Narendranath Epperla, MD, MS20

1James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
2Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
3The Ohio State University, Columbus, OH
4Fred Hutchinson Cancer Center, Seattle, WA
5Thomas Jefferson University Hospital, Philadelphia, PA
6Department of Medicine, Division of Oncology, University of North Carolina-Chapel Hill, Chapel Hill, NC
7Northwestern University, Chicago
8University of Colorado Cancer Center, Aurora, CO
9Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
10Rhode Island Hospital, Providence, RI
11Brown University, Providence, RI
12Division of Hematology, Oncology, and Transplantation, University of Minnesota Medical Center, Minneapolis, MN
13University of Colorado, Denver, CO
14Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
15Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL
16University of North Carolina, Chapel Hill, NC
17Abramson Cancer Center, The Fox Chase Cancer Center Foundation, Philadelphia, PA
18Division of Hematology, The Ohio State University, Columbus, OH
19Fred Hutchinson Cancer Research Center, Seattle, WA
20Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH

*signifies non-member of ASH